Literature DB >> 2839578

Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines.

G Zhaori1, M Sun, P L Ogra.   

Abstract

Groups of infants were immunized with high-potency, inactivated polio vaccine (IPV) or live, attenuated oral polio vaccine (OPV) and studied for antibody responses to whole virus and polypeptides VP1, VP2, and VP3. Both vaccines induced neutralizing and enzyme-linked immunosorbent assay (ELISA) IgG to the whole virus, IgG antibody to VP1 and VP3, and similar secretory IgA to VP1 and VP2 in the nasopharyngeal secretions (NPS) without any VP3 response. Virus-specific neutralizing activity in NPS was observed in 70% of subjects receiving OPV and in only 26.7% of subjects receiving IPV. ELISA antibody also appeared to be lower in IPV than in OPV subjects. These observations suggest that specific ELISA antibody to poliovirus virion proteins can be frequently induced in the secretory sites, by OPV as well as by IPV. Neutralizing antibody response in the NPS appeared, however, to be more effectively induced by OPV than by the high-potency IPV.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2839578     DOI： 10.1093/infdis/158.1.160

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice.

Authors:  S E Coffin; C A Moser; S Cohen; H F Clark; P A Offit
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

4.  An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16.

Authors:  O Jenkins; J Cason; K L Burke; D Lunney; A Gillen; D Patel; D J McCance; J W Almond
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Effects of the route of infection on immunoglobulin G subclasses and specificity of the reovirus-specific humoral immune response.

Authors:  A S Major; C F Cuff
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 6.  Immunity to enteric viruses.

Authors:  Ainsley Lockhart; Daniel Mucida; Roham Parsa
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

7.  Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.

Authors:  Mariana Manrique; Pamela A Kozlowski; Antonio Cobo-Molinos; Shainn-Wei Wang; Robert L Wilson; David C Montefiori; Angela Carville; Anna Aldovini
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Importance of innate mucosal immunity and the promises it holds.

Authors:  Abhisek Dwivedy; Palok Aich
Journal:  Int J Gen Med       Date:  2011-04-12

9.  Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.

Authors:  Kizzmekia S Corbett; Martha C Nason; Britta Flach; Matthew Gagne; Sarah O'Connell; Timothy S Johnston; Shruti N Shah; Venkata Viswanadh Edara; Katharine Floyd; Lilin Lai; Charlene McDanal; Joseph R Francica; Barbara Flynn; Kai Wu; Angela Choi; Matthew Koch; Olubukola M Abiona; Anne P Werner; Juan I Moliva; Shayne F Andrew; Mitzi M Donaldson; Jonathan Fintzi; Dillon R Flebbe; Evan Lamb; Amy T Noe; Saule T Nurmukhambetova; Samantha J Provost; Anthony Cook; Alan Dodson; Andrew Faudree; Jack Greenhouse; Swagata Kar; Laurent Pessaint; Maciel Porto; Katelyn Steingrebe; Daniel Valentin; Serge Zouantcha; Kevin W Bock; Mahnaz Minai; Bianca M Nagata; Renee van de Wetering; Seyhan Boyoglu-Barnum; Kwanyee Leung; Wei Shi; Eun Sung Yang; Yi Zhang; John-Paul M Todd; Lingshu Wang; Gabriela S Alvarado; Hanne Andersen; Kathryn E Foulds; Darin K Edwards; John R Mascola; Ian N Moore; Mark G Lewis; Andrea Carfi; David Montefiori; Mehul S Suthar; Adrian McDermott; Mario Roederer; Nancy J Sullivan; Daniel C Douek; Barney S Graham; Robert A Seder
Journal:  Science       Date:  2021-09-17       Impact factor: 47.728

10.  Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.

Authors:  Joseph R Francica; Barbara J Flynn; Kathryn E Foulds; Amy T Noe; Anne P Werner; Ian N Moore; Matthew Gagne; Timothy S Johnston; Courtney Tucker; Rachel L Davis; Britta Flach; Sarah O'Connell; Shayne F Andrew; Evan Lamb; Dillon R Flebbe; Saule T Nurmukhambetova; Mitzi M Donaldson; John-Paul M Todd; Alex Lee Zhu; Caroline Atyeo; Stephanie Fischinger; Matthew J Gorman; Sally Shin; Venkata Viswanadh Edara; Katharine Floyd; Lilin Lai; Seyhan Boyoglu-Barnum; Renee Van De Wetering; Alida Tylor; Elizabeth McCarthy; Valerie Lecouturier; Sophie Ruiz; Catherine Berry; Timothy Tibbitts; Hanne Andersen; Anthony Cook; Alan Dodson; Laurent Pessaint; Alex Van Ry; Marguerite Koutsoukos; Cindy Gutzeit; I-Ting Teng; Tongqing Zhou; Dapeng Li; Barton F Haynes; Peter D Kwong; Adrian McDermott; Mark G Lewis; Tong Ming Fu; Roman Chicz; Robbert van der Most; Kizzmekia S Corbett; Mehul S Suthar; Galit Alter; Mario Roederer; Nancy J Sullivan; Daniel C Douek; Barney S Graham; Danilo Casimiro; Robert A Seder
Journal:  Sci Transl Med       Date:  2021-07-27       Impact factor: 19.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.